Association of GLP-1 Receptor Agonist Use With Chronic Kidney Disease Risk in Type 2 Diabetes

Mayo Clinic Proceedings 2026

View at publisher

Authors: Fu-Shun Yen, Chih-Cheng Hsu, Yao‐Min Hung, Jing-Yang Huang, Chii‐Min Hwu, James Cheng-Chung Wei

DOI: 10.1016/j.mayocp.2026.01.035

Cited by: 1

References: 31

Fields of Study & Subjects

Diabetes Treatment and Management Diabetes Cardiovascular Risks and Lipoproteins Chronic Kidney Disease and Diabetes

References 31